100
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Reliability and validity of the Maltese version of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q)

, , , &
Pages 969-979 | Published online: 19 Jun 2019

References

  • Ageno W, Gallus AS, Wittkowsky A, et al. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2Suppl):e44S–88S. doi:10.1378/chest.11-229222315269
  • Borg Xuereb C, Shaw RL, Lane DA. Patients’ and physicians’ experiences of atrial fibrillation consultations and anticoagulation decision-making: A multi-perspective IPA design. Psychol Health. 2016;31(4):436–455. doi:10.1080/08870446.2015.111653426540308
  • Casais P, Meschengieser SS, Sanchez-Luceros A, Lazzari MA. Patients‘ perceptions regarding oral anticoagulation therapy and its effect on quality of life. Curr Med Res Opin. 2005;21(7):1085–1090. doi:10.1185/030079905X5062416004677
  • Phatak HM, Thomas J III. Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother. 2006;40(10):1737–1742. doi:10.1345/aph.1H15316985088
  • Waterman AD, Milligan PE, Bayer L, Banet GA, Gatchel SK, Gage BF. Effect of warfarin nonadherence on control of the International normalized ratio. Am J Health Syst Pharm. 2004;61(12):1258–1264. doi:10.1093/ajhp/61.12.125815259756
  • Prins MH, Marrel A, Carita P, et al. Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the ‘Perception of anticoagulant treatment questionnaire‘ (PACT-Q). Health Qual Life Outcomes. 2009;7:9. doi:10.1186/1477-7525-7-919196486
  • Samsa G, Matchar DB, Dolor RJ, et al. A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation. Health Qual Life Outcomes. 2004;2:22. doi:10.1186/1477-7525-2-2215132746
  • Cano SJ, Lamping DL, Bamber L, Smith S. The anti-clot treatment scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients. Health Qual Life Outcomes. 2012;10:120. doi:10.1186/1477-7525-10-12023013426
  • Hedner E, Carlsson J, Kulich KR, Stigendal L, Ingelgård A, Wiklund I. An instrument for measuring health-related quality of life in patients with deep venous thrombosis (DVT): development and validation of deep venous thrombosis quality of life (DVTQOL) questionnaire. Health Qual Life Outcomes. 2004;2:30. doi:10.1186/1477-7525-2-3015214965
  • Cohn DM, Nelis EA, Busweiler LA, Kaptein AA, Middeldorp S. Quality of life after pulmonary embolism: the development of the PEmb-QoL questionnaire. J Thromb Haemost. 2009;7(6):1044–1046. doi:10.1111/j.1538-7836.2009.03341.x19320823
  • Prins MH, Guillemin I, Gilet H, et al. Scoring and psychometric validation of the perception of anticoagulant treatment questionnaire (PACT-Q). Health Qual Life Outcomes. 2009;7:30. doi:10.1186/1477-7525-7-3019348685
  • Mohamed S, Razak TA, Hashim R. Translation, validation and psychometric properties of Bahasa Malaysia version of the perception of anticoagulant therapy questionnaire (PACTQ). Asian J Biomed Pharm Sci. 2015;5(48):18–22. doi:10.15272/ajbps.v5i48.730
  • Agnelli G, Gitt AK, Bauersachs R, et al. The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE registry. Thromb J. 2015;13:41. doi:10.1186/s12959-015-0071-z26500458
  • De Caterina R, Brüggenjürgen B, Darius H, et al. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: a PREFER in AF registry substudy. Arch Cardiovasc Dis. 2018;111(2):74–84. doi:10.1016/j.acvd.2017.04.00728942115
  • Pelegrino FM, Dantas RA, Corbi IS, Da Silva Carvalho AR, Schmidt A, Pazin Filho A. Cross-cultural adaptation and psychometric properties of the Brazilian-Portuguese version of the Duke anticoagulation satisfaction scale. J Clin Nurs. 2012;21(17–18):2509–2517. doi:10.1111/j.1365-2702.2011.03869.x22077911
  • Sousa VD, Rojjanasrirat W. Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. J Eval Clin Pract. 2011;17(2):268–274. doi:10.1111/j.1365-2753.2010.01434.x20874835
  • Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000;25(24):3186–3191.11124735
  • Webb NM, Shavelson RJ, Haertel EH. Reliability coefficients and generalizability theory In: Rao CR, Sinharay S, editors. Handbook of Statistics: Vol 26 Psychometrics. Holland: Elsevier; 2006:81–124.
  • Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;22(3):297–334. doi:10.1007/BF02310555
  • Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess. 1994;6(4):284–290. doi:10.1037/1040-3590.6.4.284
  • Wood D, Qiu L, Lu J, Lin H, Tov W. Adjusting Bilingual ratings by retest reliability improves estimation of translation quality. J Cross Cult Psychol. 2018;49(9):1325–1339. doi:10.1177/0022022118789773
  • McCrae RR, Yik MS, Trapnell PD, Bond MH, Paulhus DL. Interpreting personality profiles across cultures: bilingual, acculturation, and peer rating studies of Chinese undergraduates. J Pers Soc Psychol. 1998;74(4):1041–1055.9569658
  • Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi:10.1016/j.jclinepi.2006.03.01217161752
  • Campbell DT, Fiske DW. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull. 1959;56(2):81–105.13634291
  • McDonald RP, Ho MH. Principles and practice in reporting structural equation analyses. Psychol Methods. 2002;7(1):64–82.11928891
  • Streiner DL, Norman GR, Cairney J. Health Measurement Scales: A Practical Guide to Their Development and Use. Oxford: Oxford University Press; 2015.
  • Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236–239.8470047
  • Frey PM, Méan M, Limacher A, et al. Quality of life after pulmonary embolism: prospective validation of the German version of the PEmb-QoL questionnaire. Thromb Res. 2015;135(6):1087–1092. doi:10.1016/j.thromres.2015.03.03125887632
  • Rochat M, Méan M, Limacher A, et al. Quality of life after pulmonary embolism: validation of the French version of the PEmb-QoL questionnaire. Health Qual Life Outcomes. 2014;12:174. doi:10.1186/s12955-014-0174-425464821
  • Goette A, Kwong WJ, Ezekowitz MD, et al. Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study. EP Europace. 2018;20:1936–1943. [Epub ahead of print] PubMed PMID: 29947751. doi:10.1093/europace/euy141
  • Kooistra HA, Piersma-Wichers M, Kluin-Nelemans HC, Veeger NJ, Meijer K. Impact of vitamin K antagonists on quality of life in a prospective cohort of 807 atrial fibrillation patients. Circ Cardiovasc Qual Outcomes. 2016;9(4):388–394. doi:10.1161/CIRCOUTCOMES.115.00261227329860
  • Obamiro KO, Chalmers L, Lee K, Bereznicki BJ, Bereznicki LRE. Anticoagulation knowledge in patients with atrial fibrillation: an Australian survey. Int J Clin Pract. 2018;72(3):e13072. doi:10.1111/ijcp.1307229457323
  • Davis NJ, Billett HH, Cohen HW, Arnsten JH. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother. 2005;39(4):632–636. doi:10.1345/aph.1E46415713790
  • Thomson Mangnall LJ, Sibbritt DW, Al-Sheyab N, Gallagher RD. Predictors of warfarin non-adherence in younger adults after valve replacement surgery in the South Pacific. Heart Asia. 2016;8(2):18–23. doi:10.1136/heartasia-2016-01075127347009
  • Weernink MGM, Vaanholt MCW, Groothuis-Oudshoorn CGM, von Birgelen C, IJzerman MJ, van Til JA. Patients‘ priorities for oral anticoagulation therapy in non-valvular atrial fibrillation: a multi-criteria decision analysis. Am J Cardiovasc Drugs. 2018;18(6):493–502. doi:10.1007/s40256-018-0293-030132140
  • Vella A. Languages and language varieties in Malta. Int J Biling Educ Biling. 2013;16(5):532–552. doi:10.1080/13670050.2012.716812
  • Mazor KM, Clauser BE, Field T, Yood RA, Gurwitz JH. A demonstration of the impact of response bias on the results of patient satisfaction surveys. Health Serv Res. 2002;37(5):1403–1417.12479503
  • Radaideh KM, Matalqah LM. Health-related quality of life among atrial fibrillation patients using warfarin therapy. Epidemiol Biostatistics Public Health. 2018;15(1):e12763.1–8.